Click here for our response to the Coronavirus Pandemic (COVID-19) including information from the U.S. Department of Homeland Security on blood donation being permitted during Stay at Home directives. 

Click here for care provider and self-referrals for convalescent plasma donors for those that had a positive molecular test (also called PCR or polymerase chain reaction) and are fully recovered from COVID-19.  Email patientservices@mvrbc.org or call 833-610-1025 with questions.

AABB Circular of Information

For a hardcopy of the Circular of Information, please reach out to ClientServices@mvrbc.org.


The Circular of Information for the Use of Human Blood and Blood Components provides an extensive review of licensed and some unlicensed blood and blood components, their indications for use, special precautions, instructions for administration, and adverse effects of transfusion. It also includes a broad and up-to-date list of references. The Circular is an important part of the labeling for a blood component, similar to the package insert provided for a drug. The Code of Federal Regulations, Title 21, requires that it be available for distribution with blood and blood components intended for transfusion and that it provide adequate directions for use. The information contained in the Circular is intended to be widely available and easily accessed by health care providers as it is recognized by the FDA as an extension of the blood component label.


AABB Primer of Administration

This manual is an excellent resource for developing training programs for nurses, physicians, fellows, and residents to teach the basics of blood administration